Pulmonx counsel sells 14,334 shares for taxes

Pulmonx Corp’s General Counsel sold 14,334 LUNG shares to cover taxes on vesting RSUs.

Rhea-AI Filing Summary

Pulmonx Corp (LUNG) reported that its General Counsel, David Aaron Lehman, sold an aggregate 14,334 shares of Common Stock on September 1, 2026 at $2.26 per share in four open-market or private transactions. Footnotes state that each sale covered tax withholding obligations arising from the vesting of Restricted Stock Units granted in 2023, 2024, 2025, and 2026, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 14,334 shares

Net Sell 4 txns

Insider Lehman David Aaron

Role General Counsel

Sold 14,334 shs ($32K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	3,807	$2.26	$9K
Sale	Common Stock F2	2,224	$2.26	$5K
Sale	Common Stock F3	3,476	$2.26	$8K
Sale	Common Stock F4	4,827	$2.26	$11K

Holdings After Transaction: Common Stock — 361,827 shares (Direct)

Footnotes (4)

1. F1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
2. F2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
3. F3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
4. F4. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.

Key Figures

Total shares sold: 14,334 shares Sale price per share: $2.26 per share First tax-withholding sale: 3,807 shares +3 more

6 metrics

Total shares sold 14,334 shares Aggregate Common Stock sales by General Counsel on September 1, 2026

Sale price per share $2.26 per share Price for all reported Common Stock sales on September 1, 2026

First tax-withholding sale 3,807 shares Shares sold to cover taxes on RSUs granted March 1, 2023

Second tax-withholding sale 2,224 shares Shares sold to cover taxes on RSUs granted March 1, 2024

Third tax-withholding sale 3,476 shares Shares sold to cover taxes on RSUs granted March 3, 2025

Fourth tax-withholding sale 4,827 shares Shares sold to cover taxes on RSUs granted March 2, 2026

Key Terms

Restricted Stock Units, tax withholding obligations, open market or private transaction

3 terms

Restricted Stock Units financial

"in connection with the vesting of the Restricted Stock Units (the "RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"sold by the reporting person to cover tax withholding obligations in connection"

open market or private transaction financial

"transaction code description lists Sale in open market or private transaction"

FAQ

What insider transaction did Pulmonx Corp (LUNG) disclose for its General Counsel?

Pulmonx Corp disclosed that General Counsel David Aaron Lehman sold 14,334 shares of Common Stock on September 1, 2026 in four transactions at $2.26 per share, as reported on a Form 4.

Why did the Pulmonx Corp (LUNG) General Counsel sell 14,334 shares?

The filing states the 14,334 shares were sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on March 1, 2023; March 1, 2024; March 3, 2025; and March 2, 2026.

At what price were the Pulmonx (LUNG) shares sold by the General Counsel?

All reported transactions were executed at a price of $2.26 per share of Pulmonx Corp Common Stock on September 1, 2026, according to the Form 4 data.

How many individual transactions did the Pulmonx (LUNG) Form 4 report?

The Form 4 reports four separate sales of Pulmonx Corp Common Stock, totaling 14,334 shares, all dated September 1, 2026 and each linked by footnote to tax-related RSU vesting.

Were the Pulmonx (LUNG) insider sales under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is marked false, and there is no footnote stating that the transactions were made pursuant to a Rule 10b5-1 trading plan.

What RSU grants are associated with the Pulmonx (LUNG) insider’s tax-related sales?

Footnotes link the tax-withholding sales to RSUs granted on March 1, 2023, March 1, 2024, March 3, 2025, and March 2, 2026, whose vesting triggered the tax obligations covered by the share sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 06:20 PM Accepted by SEC EDGAR 09/03/2026 - 06:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lehman David Aaron

(Last) (First) (Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)		3,807	D	$2.26	372,354	D
Common Stock	09/01/2026		S(2)		2,224	D	$2.26	370,130	D
Common Stock	09/01/2026		S(3)		3,476	D	$2.26	366,654	D
Common Stock	09/01/2026		S(4)		4,827	D	$2.26	361,827	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.

2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.

3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.

4. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.

	/s/ David Aaron Lehman	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)